| |
| |
|
| Insider
Information: |
Watanabe Todd Franklin |
| Relationship: |
See Remarks, Director |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
860,750 |
|
|
Indirect Shares
|
231,140 |
|
|
| Direct
Value |
$6,886,000 |
|
|
|
Indirect Value
|
$1,849,120 |
|
|
| Total
Shares |
1,091,890 |
|
|
| Total
Value |
$8,735,120 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
See Remarks, Director |
2024-05-02 |
860,750 |
2024-05-02 |
231,140 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-05-02 |
4 |
AS |
$8.74 |
$120,433 |
D/D |
(13,783) |
860,750 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-03-04 |
4 |
AS |
$11.12 |
$165,739 |
D/D |
(14,903) |
874,533 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-02-28 |
4 |
AS |
$10.60 |
$26,129 |
D/D |
(2,465) |
889,436 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
264,882 |
891,901 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
627,019 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,126 |
502,019 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-12-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,126 |
24,413 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-12-01 |
4 |
OE |
$1.68 |
$100,038 |
D/D |
59,525 |
513,682 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-05-31 |
4 |
B |
$6.38 |
$9,334 |
D/D |
1,463 |
515,145 |
2.81 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-03-06 |
4 |
AS |
$15.26 |
$37,167 |
D/D |
(2,435) |
366,657 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-03-02 |
4 |
AS |
$15.82 |
$86,606 |
D/D |
(5,472) |
369,092 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-02-28 |
4 |
AS |
$16.17 |
$37,878 |
D/D |
(2,343) |
374,564 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-02-14 |
4 |
AS |
$17.02 |
$8,800 |
D/D |
(517) |
376,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-02-13 |
4 |
AS |
$17.00 |
$8,211 |
D/D |
(483) |
377,424 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-02-01 |
4 |
AS |
$17.00 |
$17,003 |
D/D |
(1,000) |
377,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2022-12-07 |
4 |
AS |
$17.06 |
$17,060 |
D/D |
(1,000) |
378,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2022-11-07 |
4 |
AS |
$18.00 |
$18,004 |
D/D |
(1,000) |
379,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-10-07 |
4 |
AS |
$19.51 |
$19,510 |
D/D |
(1,000) |
380,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-09-07 |
4 |
AS |
$21.51 |
$21,510 |
D/D |
(1,000) |
381,907 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-08-05 |
4 |
AS |
$24.74 |
$61,858 |
D/D |
(2,500) |
651,871 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-08-05 |
4 |
OE |
$1.68 |
$4,202 |
D/D |
2,500 |
654,371 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-07-08 |
4 |
AS |
$25.00 |
$342,473 |
D/D |
(13,500) |
651,871 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-07-08 |
4 |
OE |
$1.68 |
$11,910 |
D/D |
7,087 |
658,958 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-07-06 |
4 |
AS |
$22.07 |
$22,070 |
D/D |
(1,000) |
658,284 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
268,964 |
382,907 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
